The Anaemia Fight and a Missing Injection

Question (10 marks, ~150 words):

"A free-medicine scheme is judged at the pharmacy window, not on paper." In the light of essential-drug stock-outs, examine what it takes to make public health delivery reliable.

Introduction:

• A five-month stock-out of the FCM anaemia injection in Rajasthan's government hospitals — with a maternal death reported — exposes the gap between promising free medicine and delivering it.

Why it matters:

• Anaemia in pregnancy raises maternal death, preterm birth and low-birth-weight risk; iron therapy is central to the national anaemia programme.
• A drug costing Rs 2,500-6,000 privately is unaffordable for poor patients, so a stock-out directly attacks health equity.

Where the system fails:

• Procurement delays, absent buffer stocks, and weak real-time tracking of drug inventory down to the district level.

Way forward:

• Real-time stock dashboards, rate-contract procurement with buffer stocks, and accountability for stock-outs of listed essential medicines.
• Pair supply with screening, iron-folic-acid coverage and dietary awareness for durable anaemia control.

Conclusion:

• Public health is judged at the pharmacy window; a reliable supply chain, not a one-off campaign, is what keeps the free-medicine promise.